The biosensor also called as biological sensor device made up of a transducer and biological element, nucleic acid, and antibody or an enzyme. Biosensor is an analytical tool which consist of three main parts, the biological recognition element-help in segregating target molecules such as enzymes, antibody, DNA and cell in presence of various chemicals, transducer-convert bio recognition event such as ph change, heat, light and mass changes into signals which are measured in transducer part, signal processing system-convert signals into readings. Glucose biosensor helps in monitoring blood glucose level in diabetic patients which help is managing the diabetics and escaping further complications. Glucose biosensors convert biological response into an electrical signal and aid in measuring a wide spectrum of analysts together with, bacteria, grasses, organic compounds and others. Glucose measurements are based on interactions with one of three enzymes namely hexokinase, glucose oxidase (GOx) or glucose-1-dehydrogenase (GDH).
High prevalence of diabetes across the globe is expected to increase demand of glucose biosensor market
Increasing incidence of diabetes worldwide is projected to be key factor responsible for high growth of the market. Diabetic patients required continuous glucose monitoring for effective disease management, thereby increasing demand of glucose biosensors. Furthermore, technological advancements, increasing demand for minimal non-invasive products, chronic heart condition, increase in home diagnosis, emerging new non-medical applications and increasing awareness about early detection and prevention of diabetes are expected to drive the growth of global glucose biosensor market.
However, availability of alternatives for diabetes management such as laboratory methods, stiff competition, lack of standardization and knowledge about handling the devices are expected to hamper the growth of the glucose biosensor market to a certain extent
Glucose meters is the single largest selling biosensor product around the world due to upsurge in number of diabetic patients. Wearable sensors such as glucowatch which adhere to the surface of the skin maximising the wearability of the sensor. Complementary metal oxide semiconductor (CMOS) image sensors are increasingly becoming strong bio sensing tool owing to various benefits such as low power consumption, compact size and high strength of signal are the new trends in glucose biosensor market.
Do Inquiry About Report Here: https://marketresearch.biz/report/glucose-biosensor-market/#inquiry
The global glucose biosensor market report has been segmented on the basis of type, application, use, and region. On the basis of region, the global anti-obesity prescription drug market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is dominant market and is also anticipated to grow rapidly during the forecast period. As diabetes is the leading causes of illness and deaths in the U.S. With the increasing prevalence of diabetes in China and India, the Asia-Pacific market is anticipated to experience an upsurge in demand of glucose biosensor market.
Key market players in the global anti-obesity market are Roche AG, Bayer AG, Life Scan Inc., Abbott, Siemens AG, Medtronic Inc., Nova Biomedical Corp., Sysmex Corporation, Biosensors International Group, Lifesensors Inc., and Universal Biosensors.